Founded             2019

Founded

2019

Incubator      KTH Innovation

Pre-incubator

KTH Innovation

Target MarketSoft Tissue Engineering

Target Market

Tissue Engineering

Solutions       AKIMed - c12

Solutions

AKIMed - c12

 

Akira Science’s mission is to remove the barrier for soft tissue engineering with the polymer in focus.

What starts here will change the tissue engineering world. Our breakthrough innovation - AKIMed c12 filament/scaffold makes soft tissue regenerations smarter and easier. It is non-toxic, degradable, biocompatible, pliable, 3D printing-compatible, and a unique solution in the market.

At Akira Science, we envision a sustainable future where our technical expertise and customers’ needs are in a strong bonding. We work tirelessly to bring out the most innovative products to help patients regain health. YES, we can regenerate SMART

IMG_20191212_113253_Bokeh.jpg
 

akira pioneers

Operational team

ÁLVARO MORALES LÓPEZ, MSc

CEO

TIZIANA

FUOCO, PhD

CTO and Co-Founder

PABLO PENA, MSc

CFO

 
 

advisory TEAM

ANTONIO PIÑERO, MD, PhD, CEBS

Director of Preclinical Research

KRIM TALIA, PhD

Business Advisor